Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Cheng

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|July 1, 2022
Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian HamstersWen Su, Ka Tim Choy, Haogao Gu, et al.
Nature Communications|August 27, 2024
Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2Carolyn A Cohen, Nancy H L Leung, Prathanporn Kaewpreedee, et al.
Vaccine|June 14, 2022
Strength and durability of antibody responses to BNT162b2 and CoronaVacBenjamin J Cowling, Irene O L Wong, Eunice Y C Shiu, et al.
Journal of Virology|May 27, 2026
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccinesAndrea N Loes, Rosario Araceli L Tarabi, Shuk Hang Li, et al.
Nature Communications|October 21, 2022
Priming conditions shape breadth of neutralizing antibody responses to sarbecovirusesJanice Zhirong Jia, Chee Wah Tan, Samuel M S Cheng, et al.
Nature Communications|January 5, 2021
Neutralizing antibody titres in SARS-CoV-2 infectionsEric H Y Lau, Owen T Y Tsang, David S C Hui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects PersistAnnette Fox, Stephany Sánchez-Ovando, Louise Carolan, et al.
Viruses|February 28, 2023
Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and KoreaYun Young Go, Maura Carrai, Yan Ru Choi, et al.
Virology Journal|July 7, 2024
Genetic diversity of astroviruses detected in wild aquatic birds in Hong KongDaisy Y M Ng, Wanying Sun, Thomas H C Sit, et al.
The Journal of Infectious Diseases|September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated VaccineBenjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|July 1, 2022
Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian HamstersWen Su, Ka Tim Choy, Haogao Gu, et al.
Nature Communications|August 27, 2024
Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2Carolyn A Cohen, Nancy H L Leung, Prathanporn Kaewpreedee, et al.
Vaccine|June 14, 2022
Strength and durability of antibody responses to BNT162b2 and CoronaVacBenjamin J Cowling, Irene O L Wong, Eunice Y C Shiu, et al.
Journal of Virology|May 27, 2026
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccinesAndrea N Loes, Rosario Araceli L Tarabi, Shuk Hang Li, et al.
Nature Communications|October 21, 2022
Priming conditions shape breadth of neutralizing antibody responses to sarbecovirusesJanice Zhirong Jia, Chee Wah Tan, Samuel M S Cheng, et al.
Nature Communications|January 5, 2021
Neutralizing antibody titres in SARS-CoV-2 infectionsEric H Y Lau, Owen T Y Tsang, David S C Hui, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2025
Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects PersistAnnette Fox, Stephany Sánchez-Ovando, Louise Carolan, et al.
Viruses|February 28, 2023
Low Prevalence of SARS-CoV-2 Antibodies in Canine and Feline Serum Samples Collected during the COVID-19 Pandemic in Hong Kong and KoreaYun Young Go, Maura Carrai, Yan Ru Choi, et al.
Virology Journal|July 7, 2024
Genetic diversity of astroviruses detected in wild aquatic birds in Hong KongDaisy Y M Ng, Wanying Sun, Thomas H C Sit, et al.
The Journal of Infectious Diseases|September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated VaccineBenjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.
Pageof 14